Key takeaway
A systematic review found only 9 trials of AI chatbots, and 5 of the 7 studies on physical activity suggested the chatbots were promising for increasing it. Too few studies looked at diet or weight, and outcomes were reported inconsistently, so no firm conclusion on effectiveness is possible.
Study design
Trial meta-analysis
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Chatbots are being built into lifestyle programs as a cheap way to coach people at scale, yet it is unclear whether they change behavior. The authors set out to describe what these chatbots look like and do, and whether they improve physical activity, healthy eating, weight management and related outcomes.
Who and how
Systematic review. With a medical librarian, the authors searched six databases (PubMed, EMBASE, ACM Digital Library, Web of Science, PsycINFO and IEEE) for randomized controlled trials or quasi-experimental studies. Two reviewers screened studies independently, with a third resolving disagreements. Risk of bias was assessed with the National Institutes of Health quality assessment tools, and the AI Chatbot Behavior Change Model was used to describe chatbot characteristics, persuasive and relational capacity, and outcome evaluation. The review was registered in PROSPERO (CRD42020216761). The abstract does not report pooled effect sizes.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The search retrieved 1692 citations and 9 studies met the inclusion criteria: 4 randomized controlled trials and 5 quasi-experimental studies.
- 2Five out of the 7 studies on physical activity suggested chatbot interventions are promising for increasing it.
- 3Few studies targeted diet or weight status, and outcome assessments were reported inconsistently across studies.
- 4Of the 9 studies, 89% gave the chatbot a name and 33% gave it a gender (woman). 56% used a constrained, rule-based chatbot; the rest used unconstrained chatbots that resemble human-to-human conversation.
Limits & uncertainty
- 1Only 9 studies qualified, and 5 of them were quasi-experimental rather than randomized, so confidence in any effect is low.
- 2Outcomes were measured and reported differently across studies, which the authors say prevented definitive conclusions on activity, diet and weight loss.
- 3The abstract gives no effect sizes or risk-of-bias results, and the 7 activity studies are fewer than the 9 included, with no explanation of why. This reading is based on the abstract only.
What to take from it
A chatbot coach may help some people move more, but the evidence is early and small. It is not yet a proven way to change eating or lose weight. If an app advertises an AI coach, treat the claim as promising rather than established.
Reading your own data
If you try a chatbot-based coaching app, judge it by your own logs, such as daily steps or active minutes from the same wearable over several weeks, rather than by how engaging the conversation feels. Compare against your own baseline weeks, not single days.
How to read this evidence
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
This systematic review aimed to evaluate AI chatbot characteristics, functions, and core conversational capacities and investigate whether AI chatbot interventions were effective in changing physical activity, healthy eating, weight management behaviors, and other related health outcomes.
Methods
In collaboration with a medical librarian, six electronic bibliographic databases (PubMed, EMBASE, ACM Digital Library, Web of Science, PsycINFO, and IEEE) were searched to identify relevant studies. Only randomized controlled trials or quasi-experimental studies were included. Studies were screened by two independent reviewers, and any discrepancy was resolved by a third reviewer. The National Institutes of Health quality assessment tools were used to assess risk of bias in individual studies. We applied the AI Chatbot Behavior Change Model to characterize components of chatbot interventions, including chatbot characteristics, persuasive and relational capacity, and evaluation of outcomes.
Results
The database search retrieved 1692 citations, and 9 studies met the inclusion criteria. Of the 9 studies, 4 were randomized controlled trials and 5 were quasi-experimental studies. Five out of the seven studies suggest chatbot interventions are promising strategies in increasing physical activity. In contrast, the number of studies focusing on changing diet and weight status was limited. Outcome assessments, however, were reported inconsistently across the studies. Eighty-nine and thirty-three percent of the studies specified a name and gender (i.e., woman) of the chatbot, respectively. Over half (56%) of the studies used a constrained chatbot (i.e., rule-based), while the remaining studies used unconstrained chatbots that resemble human-to-human communication.
Conclusion
Chatbots may improve physical activity, but we were not able to make definitive conclusions regarding the efficacy of chatbot interventions on physical activity, diet, and weight management/loss. Application of AI chatbots is an emerging field of research in lifestyle modification programs and is expected to grow exponentially. Thus, standardization of designing and reporting chatbot interventions is warranted in the near future.
Systematic review registration
International Prospective Register of Systematic Reviews (PROSPERO): CRD42020216761 .
Sources & attribution
A systematic review of artificial intelligence chatbots for promoting physical activity, healthy diet, and weight loss.
Oh YJ, Zhang J, Fang ML, Fukuoka Y.
The international journal of behavioral nutrition and physical activity · 2021-12-11
DOI: 10.1186/s12966-021-01224-6 ↗PubMed · 34895247 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

